EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Jiawei Kongsheng Zhenzhong Pill (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway

Qiaolan Wu, Yang Zhou, Chunxue Ou, Zu Gao, Xiaolin Wu, Yue Zhao, Yuan Wang, Zhichun Wu iD, Huayun Yu iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Qiaolan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Hippocampus, Drugs, Chinese Herbal, Brain Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Independent Innovation Team Project of Jinan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the effects of Jiawei Kongsheng Zhenzhong Pill (JKZP) on rats with ischemic mild cognitive impairment (MCI) and investigate the underlying mechanisms.

Methods

The components of JKZP were analyzed using Q‐Orbitrap high‐resolution mass spectrometry (HRMS). The MCI rat model was prepared through gradual bilateral common carotid artery occlusion (BCCAO). The cognitive function, hippocampal pathological lesions, dendritic spine damage, synapse‐related, and S100 calcium‐binding protein A10 (S100A10)/tissue‐type plasminogen activator (tPA)/brain‐derived neurotrophic factor (BDNF) pathway‐associated molecules alterations were measured. Primary hippocampus neurons were subjected to oxygen‐glucose deprivation/reperfusion (OGD/R) injury, and JKZP‐containing serum was utilized for treatment. Lentiviral‐infected neurons were constructed with S100A10 knockdown using RNAi technology to investigate whether JKZP exerted its anti‐MCI effects via S100A10/tPA/BDNF pathway.

Results

A total of 64 major components, including β‐asarone, ferulic acid, loganin, senkyunolide H, and cryptotanshinone, were identified by Q‐Orbitrap HRMS technology. JKZP had a notable impact on enhancing the cognitive abilities of rats with MCI. JKZP reduced the damage to the hippocampal CA1 region neuron and synaptic structure, reversed the decrease in dendritic spines, and increased the expressions of synapse‐associated proteins such as synaptophysin (SYN), growth‐associated protein 43 (GAP43), and postsynaptic density protein 95 (PSD95). Furthermore, JKZP treatment dramatically reduced the ratio of protein of BDNF (proBDNF)/mature BDNF (mBDNF) by activating S100A10/tPA, which was confirmed in primary hippocampus neurons in vitro. Moreover, sh‐S100A10 tremendously mitigated the inhibitory action of JKZP on OGD/R‐mediated synapse injury, decreased the activity of tPA, and thus improved the downstream pathway targets’ ratio, proBDNF/mBDNF.

Conclusions

These results manifested that JKZP promoted neurological recovery after chronic cerebral ischemia by alleviating synaptic damage and activating the S100A10/tPA/BDNF pathway, thereby providing a novel perspective and a solid foundation against MCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusDrugs, Chinese HerbalBrain IschemiaAnimalsBrain-Derived Neurotrophic FactorRatsMaleCognitive DysfunctionRats, Sprague-DawleySignal TransductionTissue Plasminogen ActivatorNeuronsSynapsesDisease Models, AnimalS100 ProteinsNeuroprotective Agents

Stichwörter der Autor:innen

Jiawei Kongsheng Zhenzhong Pill (JKZP)S100 calcium‐binding protein A10 (S100A10)/tissue‐type plasminogen activator (t…mild cognitive impairment (MCI)synaptic plasticity

Substanzen

Brain-Derived Neurotrophic FactorDrugs, Chinese HerbalTissue Plasminogen ActivatorBdnf protein, ratS100 ProteinsNeuroprotective Agents

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Shandong Provincial Co-innovation Center of Classic Traditional Chinese Medicine Formula, Jinan, China.

ORCID-Profile: Zhichun Wu, Huayun Yu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Independent Innovation Team Project of Jinan

Zitieren

APA

Wu, Q., Zhou, Y., Ou, C., Gao, Z., Wu, X., Zhao, Y., Wang, Y., Wu, Z., & Yu, H. (2025). Jiawei Kongsheng Zhenzhong Pill (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway. Brain and Behavior. https://doi.org/10.1002/brb3.70328

Vancouver

Wu Q, Zhou Y, Ou C, Gao Z, Wu X, Zhao Y, et al. Jiawei Kongsheng Zhenzhong Pill (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway. Brain and Behavior. 2025. doi:10.1002/brb3.70328

BibTeX
@article{Wu2025,
  author = {Wu, Qiaolan and Zhou, Yang and Ou, Chunxue and Gao, Zu and Wu, Xiaolin and Zhao, Yue and Wang, Yuan and Wu, Zhichun and Yu, Huayun},
  title = {Jiawei Kongsheng Zhenzhong Pill (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70328}
}
Kostenlos starten →